LSI Epsilon invest in Videm

av | 15 november, 2024 | LSI Epsilon

We are super happy to present VIDEM, LSI Epsilons fifth investment. Videm provides accurate, accessible and affordable disease diagnostics to improve global health. You will also find Videm on NyTeknik – First with news about technology and IT.s newly published...

LSI Epsilon invest in BrainZell

av | 6 november, 2024 | LSI Epsilon

We are happy to welcome BrainZell to the LSI Epsilon family. By replacing and reducing traditional animal testing with cutting-edge human cell models, BrainZell are shaping a more sustainable future for medicine. We are looking forward to work with Petra Szeszula,...

LSI Epsilon invest in AAX Biotech.

av | 2 oktober, 2024 | LSI Epsilon

Say hi to AAX Biotech AB! ✨ It is with excitement and joy we present LSI Epsilon’s third investment. AAX Biotech is a Swedish biotech company enabling and accelerating the development of highly effective antibody-based medicines. We look forward to work with...

LSI Epsilon invest in Key2Brain.

av | 2 oktober, 2024 | LSI Epsilon

Hello Key2Brain AB! ✨ It is with great pleasure that we can present LSI Epsilon’s second investment. Key2Brain is a Swedish biotechnology company developing a novel and efficacious brain targeting platform technology. We look forward to work with Elisabet...

LSI Epsilon investerar i Atley Solutions.

av | 24 juni, 2024 | LSI Epsilon

Hej Atley Solutions! ✨ Det är med stor glädje vi kan presentera LSI Epsilons första investering. Atley Solutions är ett ledande bolag inom Targeted Radionuclide Therapy (TRT): en ny och banbrytande metod för att behandla spridd cancer med målsökande radioaktiva...